| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 06/27/2013 | US20130164788 Compositions and methods for reverse transcriptase-polymerase chain reaction (rt-pcr) |
| 06/27/2013 | US20130164780 Drug Identification Method |
| 06/27/2013 | US20130164779 Disposable cartridge for fluid analysis |
| 06/27/2013 | US20130164778 Two step sample loading of a fluid analysis cartridge |
| 06/27/2013 | US20130164776 Method used in a human or animal faeces sample processing system, and a sample processing system |
| 06/27/2013 | US20130164774 Methods, compositions and kits for assaying mitochondrial function |
| 06/27/2013 | US20130164773 Disposable cartridge for fluid analysis |
| 06/27/2013 | US20130164770 System and methods of log-scale concentration gradients |
| 06/27/2013 | US20130164768 Method of lipid assay and reagent for use therein |
| 06/27/2013 | US20130164756 Method for detecting mycobacterium tuberculosis and nontuberculous mycobacteria using duplex real-time polymerase chain reaction and melting curve analysis |
| 06/27/2013 | US20130164755 Microfluidic chip device for selecting a cell aptamer and method thereof |
| 06/27/2013 | US20130164754 Sample preparation devices and systems |
| 06/27/2013 | US20130164753 Diagnostic methods for colitis |
| 06/27/2013 | US20130164752 Detection of mecA Variant Strains of Methicillin-Resistant Staphylococcus Aureus |
| 06/27/2013 | US20130164751 Carcinoma diagnosis and treatment, based on odc1 genotype |
| 06/27/2013 | US20130164750 In Situ Hybridization Method And Buffer |
| 06/27/2013 | US20130164749 Deleted sequences in m. bovis bcg/m. bovis or m. tuberculosis, method for detecting mycobacteria using said sequences and vaccines |
| 06/27/2013 | US20130164747 Predicting Treatment Response in Cancer Subjects |
| 06/27/2013 | US20130164746 Mutations in SF3B1 and Chronic Lymphocytic Leukemia |
| 06/27/2013 | US20130164745 Methods for Assessing Risk for Cardiac Dysrythmia in a Human Subject |
| 06/27/2013 | US20130164744 Methods for Genetic Analysis of DNA to Detect Sequence Variances |
| 06/27/2013 | US20130164742 Droplet-Based Pyrosequencing |
| 06/27/2013 | US20130164741 Sperm cell processing methods |
| 06/27/2013 | US20130164740 Cellular Analysis of Body Fluids |
| 06/27/2013 | US20130164738 Genetic Sample Collection Systems |
| 06/27/2013 | US20130164737 Method for Separating Target Molecules or Particles from Fibrinogen-Containing Samples Including Blood Components |
| 06/27/2013 | US20130164735 Method of measuring human cyp3a inducibility |
| 06/27/2013 | US20130164734 Methods and materials for the detection of dengue virus infection |
| 06/27/2013 | US20130164733 Hepatitis-c virus testing |
| 06/27/2013 | US20130164431 Lettuce variety 79-69 rz "triplex rz" |
| 06/27/2013 | US20130164329 Cell-based methods and reagents |
| 06/27/2013 | US20130164315 Vaccines - Screening Method |
| 06/27/2013 | US20130164279 Micro RNA-148A as a Biomarker for Advanced Colorectal Cancer |
| 06/27/2013 | US20130164262 Recombinant Viruses and their Use for Treatment of Atherosclerosis and Othe Forms of Coronary Artery Disease and Method, Reagent, and Kit for Evaluating Susceptibiity to Same |
| 06/27/2013 | US20130164234 Composition for treating skin pigmentation |
| 06/27/2013 | US20130164216 Bladder cancer tumor marker, antibody and use thereof |
| 06/27/2013 | US20130161204 Reagent composition, sensor, sensor system, and sensor manufacture process |
| 06/27/2013 | DE202013004928U1 Mittel zur schnellen quantitativen und qualitativen Bestimmung von Schimmelpilzen und Hefen Means for rapid quantitative and qualitative determination of molds and yeasts |
| 06/27/2013 | DE102010022903B4 Zusammenstellung oder Kit, umfassend lebende Mikroorganismen mit Aktivitätsindikator Composition or kit comprising living microorganisms with activity indicator |
| 06/27/2013 | CA2858284A1 Detection of meca variant strains of methicillin-resistant staphylococcus aureus |
| 06/27/2013 | CA2858209A1 Methods and reagents for reducing non-specific amplification |
| 06/27/2013 | CA2856981A1 Expression signature for staging and prognosis of prostate, breast and leukemia cancers |
| 06/27/2013 | CA2854959A1 Method for determining an analyte concentration |
| 06/27/2013 | CA2852850A1 Plasma micrornas for the detection of early colorectal cancer |
| 06/26/2013 | EP2607901A1 Method for quantifying the amount of cholesterol in high-density lipoprotein 3 |
| 06/26/2013 | EP2607498A1 Genetic alterations in isocitrate dehydrogenase and other genes in malignant glioma |
| 06/26/2013 | EP2607497A1 Tests to predict responsiveness of cancer patients to chemotherapy treatment options |
| 06/26/2013 | EP2607496A1 Methods useful in nucleic acid sequencing protocols |
| 06/26/2013 | EP2607495A1 Method for detection of KRAS mutations |
| 06/26/2013 | EP2607494A1 Biomarkers for lung cancer risk assessment |
| 06/26/2013 | EP2607493A1 Diagnosis of steatohepatitis |
| 06/26/2013 | EP2607492A1 Method for determining the concentration of an analyte |
| 06/26/2013 | EP2607477A1 Multipotent stem cells and uses thereof |
| 06/26/2013 | EP2607369A1 Modified nucleotides for polynucleotide sequencing |
| 06/26/2013 | EP2606976A1 Methods and apparatus for the manipulation of particle suspensions and testing thereof |
| 06/26/2013 | EP2606909A1 Method and composition for treating, preventing and diagnosing cancer containing cancer stem cells or derived therefrom |
| 06/26/2013 | EP2606358A2 Bard1 isoforms in lung and colorectal cancer and use thereof |
| 06/26/2013 | EP2606353A1 Circulating biomarkers for disease |
| 06/26/2013 | EP2606347A2 Small molecule arrays and methods for making and using them |
| 06/26/2013 | EP2606165A1 Markers of the male urogenital tract |
| 06/26/2013 | EP2606154A2 Integrated analysis system |
| 06/26/2013 | EP2606153A2 Method for predicting and preventing cardiovascular disease |
| 06/26/2013 | EP2606152A2 Methods for determining the presence or risk of developing facioscapulohumeral dystrophy (fshd) |
| 06/26/2013 | EP2606151A2 Ndm-1 polymerase chain reaction (pcr) assay |
| 06/26/2013 | EP2606150A1 Quantitative real-time pcr assay using fret dual-labeled primers |
| 06/26/2013 | EP2606149A1 Polymerase assay with a fret substrate |
| 06/26/2013 | EP2606148A1 Helicase dependent isothermal amplification using nicking enzymes |
| 06/26/2013 | EP2606147A1 Method for isolating urea while removing objectionable co2 |
| 06/26/2013 | EP2606146A1 Induced sporulation screening method |
| 06/26/2013 | EP2606145A1 Methods and means for characterizing antibiotic resistance in microorganisms |
| 06/26/2013 | EP2606144A2 Estrous cycle monitoring by color response |
| 06/26/2013 | EP2606132A1 C6orf167 as a target gene for cancer therapy and diagnosis |
| 06/26/2013 | EP2606130A2 Camkk-beta as a target for treating cancer |
| 06/26/2013 | EP1392815B1 Enzymes having alpha amylase activity and methods of use thereof |
| 06/26/2013 | CN203021575U Anti-glyphosate transgenic soybean PCR-ELISA (Polymerase Chain Reaction-Enzyme-Linked Immunosorbent Assay) detection kit convenient to use |
| 06/26/2013 | CN203021574U Kit capable of fast detecting illegal cooking oil |
| 06/26/2013 | CN203021569U Standard molecular detection kit universal for herbicide-resistant transgenic soybean |
| 06/26/2013 | CN203021568U Combined parallel detection and diagnosis kit of leukemia-fused gene |
| 06/26/2013 | CN203021564U Congenital retinoschisis disease-causing gene mutation detection kit |
| 06/26/2013 | CN203021563U Kit for fast detecting real ingredients of leather |
| 06/26/2013 | CN103180730A Compositions and methods of identifying tumor specific neoantigens |
| 06/26/2013 | CN103180729A Small molecule arrays and methods for making and using them |
| 06/26/2013 | CN103180496A High-density biochemical array chips |
| 06/26/2013 | CN103180464A Real time cleavage assay |
| 06/26/2013 | CN103180463A A conjugate between a thiophilic solid phase and an oligonucleotide comprising a thiooxonucleotide |
| 06/26/2013 | CN103180462A Method for determining biological pathway activity |
| 06/26/2013 | CN103180461A Compositions and methods for prognosis of mesothelioma |
| 06/26/2013 | CN103180460A Method for detecting and/or quantifying human DNA |
| 06/26/2013 | CN103180459A 3-d genomic region of interest sequencing strategies |
| 06/26/2013 | CN103180458A Macronutrient sensitivity |
| 06/26/2013 | CN103180457A Method and kit for measuring cholesterol in low density lipoproteins |
| 06/26/2013 | CN103180456A Method for isolating urea while removing objectionable co2 |
| 06/26/2013 | CN103180455A Yang shiaw-der |
| 06/26/2013 | CN103180454A Biological sterilization indicator system and method |
| 06/26/2013 | CN103180453A Method for high-throughput identification of microbial antagonists against pathogens |
| 06/26/2013 | CN103180445A Treatment of alpha-l-iduronidase (idua) related diseases by inhibition of natural antisense transcript to idua |
| 06/26/2013 | CN103180441A Skin and hair color-controlling factor |
| 06/26/2013 | CN103180324A Coelenterazine derivatives and methods of using same |
| 06/26/2013 | CN103173577A Method for detecting porcine sapeloviruses based on reverse transcription loop-mediated isothermal amplification technology |
| 06/26/2013 | CN103173576A Reagent for assisting identification of arabis mosaic virus and application thereof |